Canton Strategic Holdings (CNTN) Times Interest Earned (2021 - 2025)
Canton Strategic Holdings (CNTN) posted Times Interest Earned of -$3349.2 for Q4 2025, down 1443.46% on a QoQ basis from -$217.0 in Q3 2025, and up 33.43% year-over-year from -$2510.1 in Q4 2024.
Canton Strategic Holdings (CNTN) Times Interest Earned (2021 - 2025) Analysis & Trends
Canton Strategic Holdings' Times Interest Earned history runs 5 years deep, the most recent figure standing at -$3349.2 for Q4 2025.
- Quarterly Times Interest Earned rose 33.43% year-over-year to -$3349.2 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$2738.6 (down 279.41% YoY) and the FY2025 annual result came in at -$3.96, down 225.28% from the prior year.
- Times Interest Earned was -$3349.2 for Q4 2025 at Canton Strategic Holdings, down from -$217.0 in the prior quarter.
- Across five years, Times Interest Earned topped out at $1.12 in Q4 2022 and bottomed at -$7150.2 in Q4 2023.
- A 5-year average of -$1107.7 and a median of -$331.73 in 2025 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2022 — Times Interest Earned surged 384.32% — and 2023, when it plunged 638742.65%.
- Canton Strategic Holdings' Times Interest Earned stood at -$0.39 in 2021, then surged by 384.32% to $1.12 in 2022, then plunged by 638742.65% to -$7150.2 in 2023, then climbed by 29.63% to -$5031.2 in 2024, then jumped by 33.43% to -$3349.2 in 2025.
- Business Quant data shows CNTN's Times Interest Earned at -$3349.2 in Q4 2025, -$217.0 in Q3 2025, and -$300.46 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Canton Strategic Holdings | 427.87 Mn | 427.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3,349.24 |
| Sep 30, 2025 | -217.00 |
| Jun 30, 2025 | -300.46 |
| Mar 31, 2025 | -300.63 |
| Dec 31, 2024 | -5,031.23 |
| Sep 30, 2024 | -1,284.67 |
| Jun 30, 2024 | -454.95 |
| Mar 31, 2024 | -499.43 |
| Dec 31, 2023 | -7,150.16 |
| Sep 30, 2023 | -527.77 |
| Jun 30, 2023 | -362.84 |
| Mar 31, 2023 | -442.23 |
| Dec 31, 2022 | 1.12 |
| Mar 31, 2022 | -0.84 |
| Dec 31, 2021 | -0.39 |
| Sep 30, 2021 | -2.29 |
| Jun 30, 2021 | -5.81 |
| Mar 31, 2021 | -9.90 |